Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
-
- KISHIMOTO Hideaki
- Department of Orthopedics, San-in Rosai Hospital
-
- FUKUNAGA Masao
- Department of Nuclear Medicine, Kawasaki Medical School
-
- KUSHIDA Kazuhiro
- Department of Orthopedics, Hamamatsu University School of Medicine
-
- SHIRAKI Masataka
- Research Institute and Practice for Involutional Diseases
-
- ITABASHI Akira
- Department of Clinical Laboratory Medicine, Saitama Medical School
-
- NAWATA Hajime
- Department of Internal Medicine, Faculty of Medicine, Kyushu University
-
- NAKAMURA Toshitaka
- Department of Orthopedics, University of Occupational and Environmental Health
-
- OHTA Hiroaki
- Department of Obstetrics and Gynecology, Tokyo Women's Medical University
-
- TAKAOKA Kunio
- Department of Orthopedics, Osaka City University School of Medicine
-
- OHASHI Yasuo
- Biostatistics/Epidemiology and Preventive Health Sciences, School of Health Sciences and Nursing, University of Tokyo
この論文をさがす
収録刊行物
-
- Journal of bone and mineral metabolism
-
Journal of bone and mineral metabolism 24 (5), 405-413, 2006-07-30
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1573387450197719936
-
- NII論文ID
- 10018193553
-
- NII書誌ID
- AA10747551
-
- ISSN
- 09148779
-
- 本文言語コード
- en
-
- データソース種別
-
- CiNii Articles